DK2988768T3 - Lyofilisat indeholdende et cyklisk peptid med Formel X1-GQRETPEGAEAKPWY-X2 til behandling af pulmonære ødemer - Google Patents

Lyofilisat indeholdende et cyklisk peptid med Formel X1-GQRETPEGAEAKPWY-X2 til behandling af pulmonære ødemer Download PDF

Info

Publication number
DK2988768T3
DK2988768T3 DK14718432.9T DK14718432T DK2988768T3 DK 2988768 T3 DK2988768 T3 DK 2988768T3 DK 14718432 T DK14718432 T DK 14718432T DK 2988768 T3 DK2988768 T3 DK 2988768T3
Authority
DK
Denmark
Prior art keywords
gqretpegaeakpwy
formula
treatment
cyclic peptide
pulmonary edema
Prior art date
Application number
DK14718432.9T
Other languages
English (en)
Inventor
Bernhard Fischer
Rudolf Lucas
Original Assignee
Apeptico Forschung & Entwicklung Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apeptico Forschung & Entwicklung Gmbh filed Critical Apeptico Forschung & Entwicklung Gmbh
Application granted granted Critical
Publication of DK2988768T3 publication Critical patent/DK2988768T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/191Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Otolaryngology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
DK14718432.9T 2013-04-23 2014-04-18 Lyofilisat indeholdende et cyklisk peptid med Formel X1-GQRETPEGAEAKPWY-X2 til behandling af pulmonære ødemer DK2988768T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13164829 2013-04-23
PCT/EP2014/058010 WO2014173842A1 (de) 2013-04-23 2014-04-18 Lyophilisat enthaltend ein zyklisches peptid der formel x1 -gqretpegaeakpwy-x2

Publications (1)

Publication Number Publication Date
DK2988768T3 true DK2988768T3 (da) 2021-06-21

Family

ID=48143176

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14718432.9T DK2988768T3 (da) 2013-04-23 2014-04-18 Lyofilisat indeholdende et cyklisk peptid med Formel X1-GQRETPEGAEAKPWY-X2 til behandling af pulmonære ødemer

Country Status (12)

Country Link
US (1) US10711041B2 (da)
EP (1) EP2988768B1 (da)
JP (1) JP6567502B2 (da)
KR (1) KR102217476B1 (da)
CN (1) CN105188734B (da)
AU (1) AU2014257678A1 (da)
CA (1) CA2907693C (da)
DK (1) DK2988768T3 (da)
EA (1) EA038363B1 (da)
ES (1) ES2876404T3 (da)
IL (1) IL242075B (da)
WO (1) WO2014173842A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170014472A1 (en) * 2014-03-04 2017-01-19 Apeptico Forschung Und Entwicklung Gmbh Attenuation of intrapulmonary inflammation
GB201421647D0 (en) * 2014-12-05 2015-01-21 Amcure Gmbh And Ruprecht-Karls-Universitat And Karlsruher Institut F�R Technologie CD44v6-derived cyclic peptides for treating cancers and angiogenesis related diseases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006013183A1 (en) * 2004-08-06 2006-02-09 Altana Pharma Ag Composition comprising a pulmonary surfactant and a tnf-derived peptide
ATE536593T1 (de) * 2005-12-30 2011-12-15 Datalogic Scanning Group Srl Beleuchtungslinse für einen optischen codeleser
AT506150B1 (de) * 2007-12-12 2010-01-15 Apeptico Forschung Und Entwick Zyklisches und cystein-freies peptid
WO2009158587A1 (en) * 2008-06-26 2009-12-30 Inspire Pharmaceuticals, Inc. Method for treating pulmonary diseases using rho kinase inhibitor compounds
AT507953B1 (de) * 2009-03-05 2011-02-15 Apeptico Forschung & Entwicklung Gmbh Verfahren zur vermeidung und zur behandlung einer hyperpermeabilität
AT509267A1 (de) * 2010-01-14 2011-07-15 Apeptico Forschung & Entwicklung Gmbh Organische verbindungen zur regulierung von vektoriellen ionenkanälen
DK2397151T3 (da) * 2010-06-21 2015-05-18 Apeptico Forschung & Entwicklung Gmbh Behandling af vaskulære komplikationer af diabetes
AT510585B1 (de) * 2010-11-18 2012-05-15 Apeptico Forschung & Entwicklung Gmbh Zusammensetzung umfassend ein peptid und ein hemmstoff der viralen neuraminidase

Also Published As

Publication number Publication date
JP2016518376A (ja) 2016-06-23
JP6567502B2 (ja) 2019-08-28
IL242075B (en) 2018-03-29
EP2988768A1 (de) 2016-03-02
ES2876404T3 (es) 2021-11-12
CN105188734A (zh) 2015-12-23
CA2907693A1 (en) 2014-10-30
CN105188734B (zh) 2019-03-01
EP2988768B1 (de) 2021-03-31
KR20160002813A (ko) 2016-01-08
US20160083431A1 (en) 2016-03-24
EA038363B1 (ru) 2021-08-16
CA2907693C (en) 2022-04-19
WO2014173842A1 (de) 2014-10-30
US10711041B2 (en) 2020-07-14
AU2014257678A1 (en) 2015-10-15
KR102217476B1 (ko) 2021-02-19
EA201592019A1 (ru) 2016-03-31

Similar Documents

Publication Publication Date Title
HK1216421A1 (zh) 用於治療病毒感染的治療化合物
DK2968071T3 (da) Enhed til oral levering af terapeutiske forbindelser
DK3076967T3 (da) Fremgangsmåder til behandling af residuelle symptomer på skizofreni
DK3050896T3 (da) Fremgangsmåde til fremstilling af en polypeptid-heteromultimer
DK2940135T3 (da) Heterodimeriseret polypeptid
DK2983721T4 (da) Terapeutiske indgivelsesvesikler
DK2992093T3 (da) Rengøringsmiddel indeholdende proteaser
DK2958900T3 (da) 2-aminopyrimidinderivater til behandling af virusinfektioner
DK3329884T3 (da) Implanterbar indretning til behandling af glaukom
FI20135972L (fi) Menetelmä ligniinin reaktiivisuuden lisäämiseksi
DK3495380T3 (da) Glucagon/glp-1-coagonister til behandling af obesitas
HK1223019A1 (zh) 用於治療室內塵蟎過敏的連續重叠肽
DK2827710T3 (da) Doseringsskema for echinocandin-klasse-forbindelser
DK2981255T3 (da) Terapeutiske anvendelser af empagliflozin
DK2970389T3 (da) Farmaceutiske forbindelser
HK1218298A1 (zh) 用於治療心力衰竭的環狀多肽
DK3019166T3 (da) A Pharmaceutical Combination for the Treatment of Melanoma
DK3021839T3 (da) Sammensætninger for behandling af fibrose
DK3360869T3 (da) Halogen-substitueret heterocyklisk forbindelse anvendelig til behandlingen af sygdomme forårsaget af lpa.
SMT201500256B (it) Bottone di chiusura per tessuti
DK2777689T3 (da) Ny farmaceutisk sammensætning til behandling af svampeinfektioner
DK3044229T3 (da) Peptider til anvendelse i behandlingen af oral mucositis
DK2900259T3 (da) Glycosidase-regime til behandling af infektionssygdomme
DK2886108T4 (da) Optimeret farmaceutisk formulering til behandling af inflammatoriske ændringer af øsofagus
DK2996710T3 (da) Aktivt stof til behandling af sarkopeni